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Abstract
Background:  Despite significant improvements in computational annotation of genomes,
sequences of abnormal, incomplete or incorrectly predicted genes and proteins remain abundant
in public databases. Since the majority of incomplete, abnormal or mispredicted entries are not
annotated as such, these errors seriously affect the reliability of these databases. Here we describe
the MisPred approach that may provide an efficient means for the quality control of databases. The
current version of the MisPred approach uses five distinct routines for identifying abnormal,
incomplete or mispredicted entries based on the principle that a sequence is likely to be incorrect
if some of its features conflict with our current knowledge about protein-coding genes and
proteins: (i) conflict between the predicted subcellular localization of proteins and the absence of
the corresponding sequence signals; (ii) presence of extracellular and cytoplasmic domains and the
absence of transmembrane segments; (iii) co-occurrence of extracellular and nuclear domains; (iv)
violation of domain integrity; (v) chimeras encoded by two or more genes located on different
chromosomes.
Results: Analyses of predicted EnsEMBL protein sequences of nine deuterostome (Homo sapiens,
Mus musculus, Rattus norvegicus, Monodelphis domestica, Gallus gallus, Xenopus tropicalis, Fugu rubripes,
Danio rerio and Ciona intestinalis) and two protostome species (Caenorhabditis elegans and Drosophila
melanogaster) have revealed that the absence of expected signal peptides and violation of domain
integrity account for the majority of mispredictions. Analyses of sequences predicted by NCBI's
GNOMON annotation pipeline show that the rates of mispredictions are comparable to those of
EnsEMBL. Interestingly, even the manually curated UniProtKB/Swiss-Prot dataset is contaminated
with mispredicted or abnormal proteins, although to a much lesser extent than UniProtKB/TrEMBL
or the EnsEMBL or GNOMON-predicted entries.
Conclusion: MisPred works efficiently in identifying errors in predictions generated by the most
reliable gene prediction tools such as the EnsEMBL and NCBI's GNOMON pipelines and also
guides the correction of errors. We suggest that application of the MisPred approach will
significantly improve the quality of gene predictions and the associated databases.
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Background
Seven years after the first drafts of the human genome
were published [1,2] and three years after the completion
of sequencing the human genome, the exact number of
the protein-coding genes encoded in this genome is still
unknown: the most likely estimates range between
20,000–25,000 genes [3,4]. More significantly, recent
analyses have shown that the exact genomic structure of
human protein-coding genes is correctly predicted for
only about 50–60 % of the genes [5,6]. In other words,
despite significant advances in computational gene iden-
tification, correct prediction of the genomic structure of
the protein-coding genes of higher eukaryotes is still a very
difficult task.
The main objective of our MisPred project is to develop
tools that can be used to identify mispredicted genes/pro-
teins, primarily from Metazoan genomes, in order to
inform scientists of the reliability of predictions and to
improve the quality of predictions. The key question is:
are there signs that may indicate that the predicted struc-
ture of a protein-coding gene might be erroneous? The
MisPred approach is based on the principle that a protein-
coding gene is likely to be mispredicted if some of its fea-
tures (or features of the protein it encodes) conflict with
our current knowledge about protein-coding genes and
proteins.
As a proof of principle, in the present work we describe
five approaches – based on five dogmas – to identify sus-
picious proteins that are likely to be abnormal or mispre-
dicted. Accordingly, the current version of MisPred
contains five routines, each focusing on a special type of
conflict with one of the dogmas.
(1) Conflict with the dogma that the subcellular locali-
zation of extracellular and transmembrane proteins is
defined by the presence of appropriate sequence sig-
nals. The validity of this dogma is supported by studies on
various disease-causing mutations, indicating that the
absence of functional signal peptides prevents the translo-
cation of proteins across the endoplasmic reticulum
membrane and the mislocalized protein is rapidly
degraded by the proteasome [7-13]. Similarly, the loss of
functional transmembrane helices is known to lead to the
mislocalization of membrane proteins [14,15]. A major
reason for the rapid degradation of mislocalized extracel-
lular proteins is that their extracellular (usually disul-
phide-bonded) domains are misfolded in the reductive
milieu of the cytoplasm and are recognized and degraded
by the protein quality control system of the cell [16].
In the current version of MisPred we used domain families
the members of which occur only in the extracellular
space (e.g. in secreted extracellular proteins and in the
extracellular parts of type I, type II, type III single pass or
multispanning transmembrane proteins) to identify pro-
teins that are completely or partially extracellular. The jus-
tification for this approach is that certain (usually
disulphide-rich) domain families are known to have
adapted (and are restricted) to the extracellular space: they
occur exclusively in extracellular proteins or extracytoplas-
mic parts of transmembrane proteins [17,18]. Following
identification of extracellular or transmembrane proteins
containing such extracellular 'marker' domains, we exam-
ined whether they have the sequence signals (secretory
signal peptides, signal anchors and/or transmembrane
helices) that could target these domains to the extracellu-
lar space.
According to this dogma, proteins that contain obligatory
extracellular domains but lack appropriate sequence sig-
nals (signal peptide, signal anchor and transmembrane
segments) are considered suspicious (abnormal and non-
viable) since their obligatory extracellular domains are
not delivered to the extracellular space where they are sta-
ble and properly folded.
(2) Conflict with the dogma that transmembrane pro-
teins containing both cytoplasmic and extracellular
parts have at least one transmembrane segment that
passes through the cell membrane. In the current version
of MisPred, we used protein domain families the mem-
bers of which occur exclusively in the extracellular space
and exclusively in the cytoplasmic space to identify trans-
membrane proteins and we asked whether these proteins
possess regions that pass through the cell membrane.
According to this dogma, proteins that contain both
obligatory extracellular and obligatory cytoplasmic
domains but lack transmembrane segment(s) separating
them are considered erroneous.
(3) Conflict with the dogma that obligatory extracellu-
lar and obligatory nuclear domains do not co-occur in
a single, multidomain protein [17,18]. According to this
dogma, proteins that contain both obligatory extracellular
and obligatory nuclear domains are considered abnormal
and nonviable since they cannot be delivered to a cellular
compartment where both types of domains would be cor-
rectly folded and fully functional.
(4) Conflict with the rule that the protein fold is highly
conserved in a domain family, therefore the number of
amino acid residues in closely related members of a
globular domain family usually fall into a relatively
narrow range [19,20]. This phenomenon reflects the fact
that the highly cooperative, rapid folding of protein
domains is the result of natural selection [18,21], there-
fore insertion/deletion of larger segments into/from pro-
tein domains may yield macromolecules that are unableBMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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Table 1: MisPred analysis of Swiss-Prot entries
UniProtKB/Swiss-Prot
Conflict 1 Number 
of 
proteins
Identified as 
containing an 
extracellular 
domain
Percentage Identified 
as 
suspicious 
by MisPred
Percentage* False 
positives
Percentage* True 
errors
Percentage* Annotated 
as fragment 
or chimera 
by UniProt
Identified as 
abnormal 
only by 
MisPred
Homo sapiens 15638 1431 9.2% 15 1.05% 10 0.70% 5 0.35% 4 1
Mus musculus 13186 1198 9.1% 12 1.00% 7 0.58% 5 0.42% 2 3
Rattus 
norvegicus
6043 599 9.9% 18 3.01% 2 0.33% 16 2.67% 14 2
Gallus gallus 1635 194 11.9% 22 11.34% 3 1.55% 19 9.79% 12 7
Danio rerio 1290 64 5.0% 4 6.25% 3 4.69% 1 1.56% 1 0
Caenorhabditis 
elegans
2999 119 4.0% 9 7.56% 1 0.84% 8 6.72% 0 8
Drosophila 
melanogaster
2463 147 6.0% 5 3.40% 3 2.04% 2 1.36% 1 1
Conflict 2 Number 
of 
proteins
Identified as 
containing an 
extra- and an 
intracellular 
domain
Percentage Identified 
as 
suspicious 
by MisPred
Percentage* False 
positives
Percentage* True 
errors
Percentage* Annotated 
as fragment 
or chimera 
by UniProt
Identified as 
abnormal 
only by 
MisPred
Homo sapiens 15638 43 0.3% 8 18.6% 8 18.6% 0 0.0% 0 0
Mus musculus 13186 42 0.3% 6 14.3% 6 14.3% 0 0.0% 0 0
Rattus 
norvegicus
6043 19 0.3% 2 10.5% 2 10.5% 0 0.0% 0 0
Gallus gallus 1635 10 0.6% 1 10.0% 1 10.0% 0 0.0% 0 0
Danio rerio 2999 2 0.1% 0 0.0% 0 0.0% 0 0.0% 0 0
Caenorhabditis 
elegans
1290 5 0.4% 1 20.0% 1 20.0% 0 0.0% 0 0
Drosophila 
melanogaster
2463 8 0.3% 1 12.5% 1 12.5% 0 0.0% 0 0
Conflict 3 Number 
of 
proteins
Identified 
as 
suspicious 
by MisPred
Percentage* False 
positives
Percentage* True 
errors
Percentage* Annotated 
as fragment 
or chimera 
by UniProt
Identified as 
abnormal 
only by 
MisPred
Homo sapiens 15638 0 0.0% 0 0.0% 0 0.0% 0 0
Mus musculus 13186 0 0.0% 0 0.0% 0 0.0% 0 0
Rattus 
norvegicus
6043 0 0.0% 0 0.0% 0 0.0% 0 0
Gallus gallus 1635 0 0.0% 0 0.0% 0 0.0% 0 0
Danio rerio 2999 0 0.0% 0 0.0% 0 0.0% 0 0
Caenorhabditis 
elegans
1290 0 0.0% 0 0.0% 0 0.0% 0 0
Drosophila 
melanogaster
2463 0 0.0% 0 0.0% 0 0.0% 0 0
Conflict 4 Number 
of 
proteins
Proteins 
containing 
domains 
suitable for 
the study of 
domain 
integrity
Percentage Identified 
as 
suspicious 
by MisPred
Percentage* False 
positives
Percentage* True 
errors
Percentage* Annotated 
as fragment 
or chimera 
by UniProt
Identified as 
abnormal 
only by 
MisPred
Homo sapiens 15638 6973 44.6% 10 0.14% 6 0.09% 4 0.06% 3 1
Mus musculus 13186 5808 44.0% 3 0.05% 2 0.03% 1 0.02% 1 0
Rattus 
norvegicus
6043 2756 45.6% 14 0.51% 0 0.00% 14 0.51% 13 1
Gallus gallus 1635 755 46.2% 8 1.06% 0 0.00% 8 1.06% 8 0
Danio rerio 1290 355 27.5% 1 0.28% 0 0.00% 1 0.28% 1 0
Caenorhabditis 
elegans
2999 1215 40.5% 2 0.16% 0 0.00% 2 0.16% 0 2
Drosophila 
melanogaster
2463 1203 48.8% 0 0.00% 0 0.00% 0 0.00% 0 0BMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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to rapidly adopt a correctly folded, viable and stable three-
dimensional structure. Accordingly, proteins containing
domains that consist of a significantly larger or smaller
number of residues than closely related members of the
same family may be suspected to be abnormal and nonvi-
able.
(5) Conflict with the dogma that a protein is encoded
by exons located on a single chromosome. According to
this dogma, chimeric proteins whose parts are encoded by
two or more different genes located on distinct chromo-
somes are considered abnormal.
In the present work we describe the results of MisPred
analyses of various public databases and discuss the val-
ues and limitations of the MisPred approach.
Results and discussion
Validation of the MisPred approach on the Swiss-Prot 
section of the UniProtKB
The Swiss-Prot section of UniProtKB is the gold standard
of protein databases therefore we have used Swiss-Prot as
the benchmark with which to validate the concepts
behind the MisPred approach. In view of the high quality
of this manually curated database our original expectation
was that very few, if any, of the Swiss-Prot entries are truly
erroneous therefore it would provide a useful dataset with
which to test the specificity of the different MisPred rou-
tines.
MisPred analyses of human, mouse, rat, chick, zebrafish,
worm and fly Swiss-Prot entries have indeed identified
very few Swiss-Prot entries as truly erroneous (see Table
1). The details of the analyses of the Swiss-Prot entries are
described in Additional file 1 [see Additional file 1] and
the list of the erroneous entries is deposited in Additional
file 2 [see Additional file 2]. The majority of these errors
could be corrected by targeted search of genomic and EST
databases; the protocol used for the correction of errors
will be described in another publication (manuscript in
preparation).
The majority of truly erroneous sequences were returned
for Conflicts 1 and 4, however, these accounted for only
0.03–1.16% and 0.008–0.49% of the sequences of the dif-
ferent species, respectively.
There were three major types of true positives among the
Swiss-Prot entries identified by Conflict 1:
1) Fragments of full-length proteins that are not known to
be fragments and/or are not annotated as such in the data-
base. For example, LPLC4_HUMAN [Swiss-Prot:P59827]
proved to be a fragment and its missing signal peptide
could be predicted with the help of the sequence of a full-
length mouse ortholog (Figure 1). Similarly, the sequence
of C209C_MOUSE [Swiss-Prot:Q91ZW9] (lacking a
transmembrane helix) could be corrected by targeted
search of mouse genomic and EST sequences (Figure 2).
2) Mispredicted proteins. The hypothetical worm protein
YL15_CAEEL [Swiss-Prot:Q11101] is an example for this
type of error. The protein arose through in silico fusion of
a gene related to the homeobox protein HM07_CAEEL
[Swiss-Prot:P20270] and a gene related to the
Kunitz_BPTI containing protein CBG14258,
Q619J1_CAEBR [TrEMBL:Q619J1] (Figure 3).
3) Proteins translated from aberrant transcripts that do
not encode viable proteins. For example NOE2_MOUSE
[Swiss-Prot:Q8BM13] lacks a signal peptide, whereas the
rat ortholog [RefSeq:NP_001015017] and a different iso-
form of this mouse protein [GenBank:EDL25126] do pos-
sess a signal sequence.
The MisPred routine used for the detection of Conflict 1 is
characterized by a very low number of false positives.
There are three main sources of false positives:
1) Some proteins are identified as suspicious due to the
limitations of the bioinformatic tools incorporated in this
MisPred routine (e.g. failure to detect some signal pep-
tides and transmembrane helices).
Conflict 5 Number 
of 
proteins
Identified 
as 
suspicious 
by MisPred
Percentage* False 
positives
Percentage* True 
errors
Percentage* Annotated 
as fragment 
or chimera 
by UniProt
Identified as 
abnormal 
only by 
MisPred
Homo sapiens 15638 5 0.03% 3 0.02% 2 0.01% 0 2
Mus musculus 13186 0 0.00% 0 0.00% 0 0.00% 0 0
Rattus 
norvegicus
6043 5 0.08% 3 0.05% 2 0.03% 0 2
Gallus gallus 1635 0 0.00% 0 0.00% 0 0.00% 0 0
Danio rerio 1290 18 1.40% 18 1.40% 0 0.00% 0 0
Caenorhabditis 
elegans
2999 0 0.00% 0 0.00% 0 0.00% 0 0
Drosophila 
melanogaster
2463 0 0.00% 0 0.00% 0 0.00% 0 0
*Values for suspicious, false positive and true positive sequences are expressed as percentage of the proteins relevant for the given conflict.
Table 1: MisPred analysis of Swiss-Prot entries (Continued)BMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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2) Exceptions to the dogma on which this MisPred routine
is based, i.e. some secreted proteins truly lack secretory
signal peptides since they are subject to leaderless protein
secretion [22], such as the secreted proteins
GAPR1_HUMAN [Swiss-Prot:Q9H4G4] and
TINAG_HUMAN [Swiss-Prot:Q9UJW2].
3) Exceptions to the rule that all members of an extracel-
lular domain family are restricted to the extracellular
space.
MisPred routine based on Conflict 4 also identified a
number of truly erroneous entries. A major source for this
type of error is that the Swiss-Prot entry corresponds to an
incomplete protein (with a truncated domain). For exam-
ple, the sequence of EPHA5_RAT [Swiss-Prot: P54757]
contains only a fragment of a SAM_1 domain since the
protein sequence is truncated at the C-terminal end (Fig-
ure 4). The error in EPHA5_RAT could be corrected by tar-
geted search of the rat genome using the sequences of the
full-length orthologs (see Figure 4).
The routine based on Conflict 5 identified no erroneous
mouse, chicken, worm or fruitfly Swiss-Prot proteins and
the proportion of trans-chromosomal chimeras is very
low in the case of human (0.01%) and rat (0.03%)
sequences. On the other hand, the frequency of suspected
chimeras is relatively high in the case of zebrafish (1.4%).
As discussed in Additional file 1 [see Additional file 1], the
most likely explanation for this observation is that they
are false positives: the chromosomal assignment of con-
tigs encoding different parts of these zebrafish genes may
not be correct.
MisPred analyses have revealed that none of the Swiss-
Prot entries violate the rules underlying Conflicts 2 and 3.
Error detected by MisPred routine for Conflict 1: the case of the Swiss-Prot entry LPLC4_HUMAN Figure 1
Error detected by MisPred routine for Conflict 1: the case of the Swiss-Prot entry LPLC4_HUMAN. The protein 
contains extracellular domains LBP_BPI_CETP and LBP_BPI_CETP_C but was found to lack both a signal peptide and trans-
membrane helices. The human sequence was corrected (LPLC4_HUMAN_corrected) by targeted search of the human 
genome with its mouse ortholog, CAM20161 [EMBL:CAM20161] that has a signal peptide. The alignment shows the N-termi-
nal parts of LPLC4_HUMAN, CAM20161 and LPLC4_HUMAN_corrected. The predicted signal peptides of CAM20161 and 
LPLC4_HUMAN_corrected are in yellow and underlined.
   1                                               50
lplc4_human_corrected MWMAWCVAALSVVAVCGTSHETNTVLRVTKDVLSNAISGMLQQSDALHSA
          lplc4_human  ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~MLQQSDALHSA 
             CAM20161  MWTAWCVAALSVAAVCGIRQDTTTVLRVTKDVLGNAISGTIQKSDAFRSA
                       51                                             100
lplc4_human_corrected  LREVPLGVGDIPYNDFHVRGPPPVYTNGKKLDGIYQYGHIETNDNTAQLG 
          lplc4_human  LREVPLGVGDIPYNDFHVRGPPPVYTNGKKLDGIYQYGHIETNDNTAQLG 
             CAM20161  LREVPVGVGGVPYNDFHVREPPPKYTNGRQLGGNYKYGHIKANDNRAQLG 
                       101                                            150
lplc4_human_corrected  GKYRYGEILESEGSIRDLRNSGYRSAENAYGGHRGLGRYRAA....PVGR 
          lplc4_human  GKYRYGEILESEGSIRDLRNSGYRSAENAYGGHRGLGRYRAA....PVGR
             CAM20161  GKYRYGEILDSDGSLRDLRHEDYRPPDSAY..HRGSGRYRSAADSSSVGR 
                       151                                            200
lplc4_human_corrected  LHRRELQPGEIPPGVATGAVGPGGLLGTGGMLAADGILAGQGGLLGGGGL 
          lplc4_human  LHRRELQPGEIPPGVATGAVGPGGLLGTGGMLAADGILAGQGGLLGGGGL 
             CAM20161  LYRRELRPGEIPAGVATGALGPGGLLGTGGMLANEGILAGQGGLLGGGGL 
                       201                                            250
lplc4_human_corrected  LGDGGLLGGGGVLGVLGEGGILSTVQGITGLRIVELTLPRVSVRLLPGVG
          lplc4_human  LGDGGLLGGGGVLGVLGEGGILSTVQGITGLRIVELTLPRVSVRLLPGVG 
             CAM20161  LGDGGLLGGGGVLGVLGEGGILSTVQGITGLRIVELTLPRVSVRLLPGVGBMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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The fact that the number of Swiss-Prot entries identified
by MisPred as erroneous is very low attests to both the
high quality of this database and the reliability of the Mis-
Pred approach. Assuming that the vast majority of the
Swiss-Prot sequences that were not detected by MisPred
routines are true negatives the false positive rate of the
routines was calculated to be ≤ 0.001, i.e. their specificity
is very high (≥ 0.999).
MisPred analysis of the TrEMBL section of UniProtKB
The primary motivation for MisPred analysis of Uni-
ProtKB/TrEMBL was that TrEMBL entries are used in vari-
ous types of evidence-based, extrinsic gene prediction
programs and thus have a strong influence on the quality
of gene predictions. The results of the analyses of human
proteins are summarized in Table 2.
The data shown in Table 2 indicate that the proportion of
suspicious TrEMBL entries is relatively high in the case of
Conflict 1, Conflict 4 and Conflict 5. Importantly, these
values are orders of magnitude higher than those for the
Swiss-Prot entries, indicating that the vast majority of
TrEMBL proteins identified by MisPred as suspicious are
truly erroneous.
Error detected by MisPred routine for Conflict 1: the case of the Swiss-Prot entry C209C_MOUSE Figure 2
Error detected by MisPred routine for Conflict 1: the case of the Swiss-Prot entry C209C_MOUSE. The protein 
contains an extracellular C-type lectin domain but was found to lack both a signal peptide and transmembrane helices, whereas 
all closely related proteins (e.g. C209A_MOUSE, C209D_MOUSE [Swiss-Prot:Q91ZX1, Q91ZW8]) are type II transmem-
brane proteins. The sequence of this protein was corrected by targeted search of mouse genomic and EST sequences. The 
alignment shows the N-terminal parts of C209C_MOUSE, C209C_MOUSE_corrected, C209A_MOUSE and C209D_MOUSE. 
The predicted transmembrane helices of C209C_MOUSE_corrected, C209A_MOUSE and C209D_MOUSE are in red and 
underlined.
                       1                                               50 
          c209c_mouse  ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
c209c_mouse_corrected  MNDSAEGRVQQLGSLDEEHLIPSGTRYSFKGFRFQSPYVLKKTAGYLCHG
          c209a_mouse  MSDSKEMGKRQLRPLDEELLTSSHTRHSIKGFGFQTNSGFSSFTGCLVHS
          c209d_mouse  MSDSMESKTQQVVIPEDEECLMSGTRYSDISSRLQTKFGIKSLAEYTKQS
                       51                                             100 
          c209c_mouse  ~~~~~~~~~~~~MRMHTRLQFLKRVSNVAYSHGQEQAKKEKVYKEMTQLK
c209c_mouse_corrected  LGPFVLQLFCLTLSTILLLAILVKVSNVAYSHGQEQAKKEKVYKEMTQLK
          c209a_mouse  QVPLALQVLFLAVCSVLLVVILVKVYKIPSS..QEENNQMNVYQELTQLK
          c209d_mouse  RNPLVLQLLSFLFLAGLLLIILILVSKVPSSEVQN.....KIYQELMQLK
                       101                                            150 
          c209c_mouse  SQI.NRLCRPCPWDWTVFQGNCYFFSKFQQNWNDSVNACRKLDAQLVVIK
c209c_mouse_corrected  SQI.NRLCRPCPWDWTVFQGNCYFFSKFQQNWNDSVNACRKLDAQLVVIK
          c209a_mouse  AGV.DRLCRSCPWDWTHFQGSCYFFSVAQKSWNDSATACHNVGAQLVVIK
          c209d_mouse  AEVHDGLCQPCARDWTFFNGSCYFFSKSQRNWHNSTTACQELGAQLVIIE
                       151                                            200 
          c209c_mouse  SDDEQSFLQQTSKEKGYAWMGLSDLKHEGRWHWVDGSHLLFSFMKYWNKG
c209c_mouse_corrected  SDDEQSFLQQTSKEKGYAWMGLSDLKHEGRWHWVDGSHLLFSFMKYWNKG
          c209a_mouse  SDEEQNFLQQTSKKRGYTWMGLIDMSKESTWYWVDGSPLTLSFMKYWSKG
          c209d_mouse  TDEEQTFLQQTSKARGPTWMGLSDMHNEATWHWVDGSPLSPSFTRYWNRG
                       201                                    242 
          c209c_mouse  EPNNEWEEDCAEFRGDGWNDAPCTIKKYWICKK.SAMSCTEK 
c209c_mouse_corrected  EPNNEWEEDCAEFRGDGWNDAPCTIKKYWICKK.SAMSCTEK 
          c209a_mouse  EPNNLGEEDCAEFRDDGWNDTKCTNKKFWICKK.LSTSCPSK 
          c209d_mouse  EPNNVGDEDCAEFSGDGWNDLSCDKLLFWICKKVSTSSCTTKBMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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Error detected by MisPred routine for Conflict 1: the case of the Swiss-Prot entry YL15_CAEEL Figure 3
Error detected by MisPred routine for Conflict 1: the case of the Swiss-Prot entry YL15_CAEEL The hypothetical 
homeobox protein C02F12.5 [EnsEMBL: C02F12.5] predicted for chromosome X contains an extracellular Kunitz_BPTI 
domain but was found to lack both a signal peptide and transmembrane helices. This protein, that also contains a nuclear 
Homeobox domain, arose through in silico fusion of a gene related to the homeobox protein HM07_CAEEL and a gene related 
to the Kunitz_BPTI containing protein CBG14258, Q619J1_CAEBR. (A) Alignment of YL15_CAEEL and Q619JI_CAEBR shows 
close homology only in the C-terminal region, highlighted in yellow. (B) Alignment of the YL15_CAEEL_corr1 and 
HM07_CAEEL. (C) Alignment of YL15_CAEEL_corr2 and Q619J1_CAEBR.
A
                 1                                               50 
     yl15_caeel  MTSKTNMTSNKFAYDFFPWSNDTNSSQQIKNIKPPPKRSNRPTKRTTFTS
   q619j1_caebr  ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
                 51                                             100 
     yl15_caeel  EQVTLLELEFAKNEYICKDRRGELAQTIELTECQVKTWFQNRRTKKRSSE
   q619j1_caebr  ~~~~~~~~~~~~~~~~~~~~MFVWSAAVLIFSSVVPTFAQYGCI....SE
                 101                                            150 
     yl15_caeel  LKFGTACSENKTSTKWYYDSKLLFCYPYKYLGCGEGSNSFESNENCLESC
   q619j1_caebr  LTFGKACPQNKTSTKWFFDAKLSFCYPYQFLGCDEGSNSFESSDICLESC
                 151                                            200 
     yl15_caeel  KPADQFSCGGNTGPDGVCFAHGDQGCKKGTVCVMGGMVGFCCDKKIQDEW
   q619j1_caebr  KPADQFSCGGNTDADGICFSPSDSGCKKGTDCVMGGNIGFCCNKATQDEW
                 201                                            250 
     yl15_caeel  NKENSPKCLKGQVVQFKQWFGMTPLIGRSCSHNFCPEKSTCVQGKWTAYC
   q619j1_caebr  NKEHSPTCSKGSVVQFKQWFGMTPLIGRNCAHKFCPAGSTCIQGKWTAHC
                 251
     yl15_caeel  CQ 
   q619j1_caebr  CQ 
B
                 1                                               50 
yl15_caeel_corr1  MTSKTNMTSNKFAYDFFPWSNDTNSSQQIKNIKPPPKRSNRPTKRTTFTS
     hm07_caeel  ~~~~~~~~~~~~~~~~~~MKHEMVFTFLLMMVRPEASTSRIPRRRTTFTV
                 51                                             100 
yl15_caeel_corr1  EQVTLLELEFAKNEYICKDRRGELAQTIELTECQVKTWFQNRRTKKRSFI
     hm07_caeel  EQLYLLEMYFAQSQYVGCDERERLARILSLDEYQVKIWFQNRRIRMRREA
                 101 
yl15_caeel_corr1  ~~ 
     hm07_caeel  NK 
C 
     1                                               50 
yl15_caeel_corr2  MLFFTLLIQLF..LVPVLCQYACSSELKFGTACSENKTSTKWYYDSKLLF
   q619j1_caebr  MFVWSAAVLIFSSVVPTFAQYGCISELTFGKACPQNKTSTKWFFDAKLSF
                 51                                             100 
yl15_caeel_corr2  CYPYKYLGCGEGSNSFESNENCLESCKPADQFSCGGNTGPDGVCFAHGDQ
   q619j1_caebr  CYPYQFLGCDEGSNSFESSDICLESCKPADQFSCGGNTDADGICFSPSDS
                 101                                            150 
yl15_caeel_corr2  GCKKGTVCVMGGMVGFCCDKKIQDEWNKENSPKCLKGQVVQFKQWFGMTP
   q619j1_caebr  GCKKGTDCVMGGNIGFCCNKATQDEWNKEHSPTCSKGSVVQFKQWFGMTP
                 151                      178 
yl15_caeel_corr2  LIGRSCSHNFCPEKSTCVQGKWTAYCCQ 
   q619j1_caebr  LIGRNCAHKFCPAGSTCIQGKWTAHCCQ BMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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Error detected by MisPred routine for Conflict 4: the case of the Swiss-Prot entry EPHA5_RAT Figure 4
Error detected by MisPred routine for Conflict 4: the case of the Swiss-Prot entry EPHA5_RAT. This protein 
contains a C-terminal truncated SAM_1 domain that deviates significantly from the normal size of this domain family. It is note-
worthy that orthologs from mouse, human and chicken contain an intact SAM_1 domain. The sequence of this protein was 
corrected by targeted search of the rat genome using the sequences of the full-length orthologs. The alignment shows the C-
terminal parts of EPHA5_RAT, EPHA5_RAT_corrected, EPHA5_MOUSE [Swiss-Prot:Q60629], EPHA5_HUMAN [Swiss-
Prot:P54756] and EPHA5_CHICK [Swiss-Prot:P54755]. The region of the predicted SAM_1 domain of 
EPHA5_RAT_corrected that is absent in EPHA5_RAT is underlined and highlighted in yellow.
                      751                                            800 
 epha5_rat_corrected  PVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGIAAGMKYLSDMGYV
           epha5_rat  PVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGIAAGMKYLSDMGYV
         epha5_human  PVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYV
         epha5_chick  PVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGIASGMKYLSDMGYV
         epha5_mouse  PVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGIAAGMKYLSDMGYV
                      801                                            850 
 epha5_rat_corrected  HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP
           epha5_rat  HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP
         epha5_human  HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP
         epha5_chick  HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP
         epha5_mouse  HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP
                      851                                            900 
 epha5_rat_corrected  EAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRL
           epha5_rat  EAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRL
         epha5_human  EAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRL
         epha5_chick  EAIAFRKFTSASDVWSYGIVMWEVMSYGERPYWEMTNQDVIKAVEEGYRL
         epha5_mouse  EAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRL
                      901                                            950 
 epha5_rat_corrected  PSPMDCPAALYQLMLDCWQKDRNSRPKFDDIVNMLDKLIRNPSSLKTLVN
           epha5_rat  PSPMDCPAALYQLMLDCWQKDRNSRPKFDDIVNMLDKLIRNPSSLKTLVN
         epha5_human  PSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRNPSSLKTLVN
         epha5_chick  PSPMDCPAALYQLMLDCWQKDRNSRPKFDEIVSMLDKLIRNPSSLKTLVN
         epha5_mouse  PSPMDCPAALYQLMLDCWQKDRNSRPKFDEIVNMLDKLIRNPSSLKTLVN
                      951                                           1000 
 epha5_rat_corrected  ASSRVSTLLAEHGSLGSGAYRSVGEWLEATKMGRYTEIFMENGYSSMDAV
           epha5_rat  ASSRVSTLLAEHGSLGSGAYRSVGEWLEATKMGRYTEIFMENGYSSMDAV
         epha5_human  ASCRVSNLLAEHSPLGSGAYRSVGEWLEAIKMGRYTEIFMENGYSSMDAV
         epha5_chick  ASSRVSNLLVEHSPVGSGAYRSVGEWLEAIKMGRYTEIFMENGYSSMDSV
         epha5_mouse  ASSRVSTLLAEHGSLGSGAYRSVGEWLEAIKMGRYTEIFMENGYSSMDAV
                      1001                                 1041 
 epha5_rat_corrected  AQVTLEDLRRLGVTLVGHQ.KKIMNSLQEMKVQLVNGMVPV
           epha5_rat  AQVTLE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
         epha5_human  AQVTLEDLRRLGVTLVGHQ.KKIMNSLQEMKVQLVNGMVPL 
         epha5_chick  AQVTLEDLRRLGVTLVGHQ.KKIMNSLQEMKVQLVNGMVPL 
         epha5_mouse  AQVTLEDLRRLGVTLVGHQKKKIMSSLQEMKVQMVNGMVPVBMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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The majority (58.0%) of human TrEMBL proteins con-
taining at least one extracellular domain were found by
MisPred to lack a signal peptide and/or a transmembrane
segment in contrast to 1.05% in the case of human Swiss-
Prot entries. Similarly, 14.8% of human TrEMBL entries
containing at least one member of the Pfam-A domain
families suitable for the study of domain integrity were
found to contain a domain of abnormal size, while this
value is only 0.14% in Swiss-Prot. The reason why a high
proportion of TrEMBL proteins are identified by Conflict
1 as suspicious is that many TrEMBL entries are truncated
at the N-terminal end and N-terminally truncated secreted
proteins are likely to lack the signal peptides. Similarly,
the high proportion of TrEMBL entries affected by Con-
flict 4 reflects the severe contamination of this database
with proteins predicted for incomplete cDNAs. Since
cDNAs are more likely to be incomplete at their 5' end
than their 3' end, the size of Pfam-A domains at the N-ter-
minal end of proteins of the TrEMBL database was found
to deviate more significantly from the average size than
those of internal domains (data not shown), again indi-
cating that a relatively large proportion of TrEMBL entries
are truncated at the N-terminal end. In harmony with this
explanation, 95% (Conflict 1) and 100% (Conflict 4) of
the suspicious entries are also annotated as fragments in
TrEMBL.
Table 2: MisPred analysis of TrEMBL entries
UniProtKB/TrEMBL
Conflict 1 Number 
of 
proteins
Identified as 
containing an 
extracellular 
domain
Percentage Identified as 
suspicious by 
MisPred
Percentage* False 
positives
Percentage* True 
errors
Percentage* Annotated 
as fragment 
or chimera 
by UniProt
Identified as 
abnormal 
only by 
MisPred
Homo sapiens 52237 6732 12.9% 3907 58.0% ND ND ND ND ND ND
Conflict 2 Number 
of 
proteins
Identified as 
containing an 
extra- and an 
intracellular 
domain
Percentage Identified as 
suspicious by 
MisPred
Percentage* False 
positives
Percentage* True 
errors
Percentage* Annotated 
as fragment 
or chimera 
by UniProt
Identified as 
abnormal 
only by 
MisPred
Homo sapiens 52237 58 0.11% 9 15.5% 9 15.5% 0 0.0% 0 0
Conflict 3 Number 
of 
proteins
Identified as 
suspicious by 
MisPred
Percentage* False 
positives
Percentage* True 
errors
Percentage* Annotated 
as fragment 
or chimera 
by UniProt
Identified as 
abnormal 
only by 
MisPred
Homo sapiens 52237 0 0.0% 0 0.0% 0 0.0% 0 0
Conflict 4 Number 
of 
proteins
Proteins 
containing 
domains 
suitable for 
the study of 
domain 
integrity
Percentage Identified as 
suspicious by 
MisPred
Percentage* False 
positives
Percentage* True 
errors
Percentage* Annotated 
as fragment 
or chimera 
by UniProt
Identified as 
abnormal 
only by 
MisPred
Homo sapiens 52237 17073 32.7% 2531 14.8% ND ND ND ND ND ND
Conflict 5 Number 
of 
proteins
Identified as 
suspicious by 
MisPred
Percentage* False 
positives
Percentage* True 
errors
Percentage* Annotated 
as fragment 
or chimera 
by UniProt
Identified as 
abnormal 
only by 
MisPred
Homo sapiens 52237 172 0.33% 0 0.00% 172 0.33% 85 87
Mus musculus 50304 40 0.08% ND ND ND ND ND ND
Rattus 
norvegicus
8557 5 0.06% ND ND ND ND ND ND
Gallus gallus 5549 6 0.11% ND ND ND ND ND ND
Danio rerio 19623 387 1.97% ND ND ND ND ND ND
Caenorhabditis 
elegans
30000 0 0.00% 0 0 0 0 0 0
Drosophila 
melanogaster
26947 49 0.18% ND ND ND ND ND ND
*Values for suspicious, false positive and true positive sequences are expressed as percentage of the proteins relevant for the given conflict.
ND – not determinedBMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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Error detected by MisPred routine for Conflict 5: the case of the protein Q9NXI4_HUMAN Figure 5
Error detected by MisPred routine for Conflict 5: the case of the protein Q9NXI4_HUMAN. The cDNA of this 
hypothetical protein FLJ20227, cloned from colon mucosa is derived from a chimera of two genes located on chromosome 11 
and chromosome 2. The N-terminal part of the protein (underlined and highlighted in yellow) is derived from the gene encod-
ing the PR domain zinc finger protein 10, PRD10_HUMAN (A), the C-terminal part of the protein (underlined and highlighted 
in blue) is derived from the gene encoding liver fatty acid-binding protein, FABPL_HUMAN (B).
A
               951                                          1000
 prd10_human  QQQNSSVQHTYLPSAWNSFRGYSSEIQMMTLPPGQFVITDSGVATPVTTG
q9nxi4_human  QQQNSSVQHTYLPSAWNSFRGYSSEIQMMTLPPGQFVITDSGVATPVTTG
              1001                                          1050
 prd10_human  QVKAVTSGHYVLSESQSELEEKQTSALSGGVQVEPPAHSDSLDPQTNSQQ
q9nxi4_human  QVKAVTSGHYVLSESQSELEEKQTSALSGGVQVEPPAHSDSLDPQTNSQQ
              1051                                          1100
 prd10_human  QTTQYIITTTTNGNGSSEVHITKP~~~~~~~~~~~~~~~~~~~~~~~~~~
q9nxi4_human  QTTQYIITAGSKVI.QNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTT
              1101                         1133 
 prd10_human  ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
q9nxi4_human  FKNIKSVTELNGDIITNTMTLGDIVFKRISKRI
B
              701                                            750
 fabpl_human  ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
q9nxi4_human  EPTASAPSSAQVSGQPLSPSAQQAQQGLSPSHIQGSSSTQGQALQQQQQQ 
              751                                            800
 fabpl_human  ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
q9nxi4_human  QQNSSVQHTYLPSAWNSFRGYSSEIQMMTLPPGQFVITDSGVATPVTTGQ 
              801                                            850
 fabpl_human  ~~MSFSGKYQL.QSQENFEAFMKAI...GLPEELIQKGKDIKGVSEIVQN 
q9nxi4_human  VKAVTSGHYVLSESQSELEEKQTSALSGGVQVEPPAHSDSLDPQTNSQQ. 
              851                                            900
 fabpl_human  GKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTT
q9nxi4_human  .QTTQYIITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTT
              901                           933 
 fabpl_human  FKNIKSVTELNGDIITNTMTLGDIVFKRISKRI
q9nxi4_human  FKNIKSVTELNGDIITNTMTLGDIVFKRISKRIBMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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Table 3: MisPred analysis of EnsEMBL entries
EnsEMBL
Conflict 1 Number of 
proteins
Identified as 
containing an 
extracellular domain
Percentage Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True 
errors
Percentage*
Homo sapiens 48403 3449 7.13% 277 8.03% ND ND ND ND
Mus musculus 31302 2038 6.51% 151 7.41% ND ND ND ND
Rattus 
norvegicus
33745 2390 7.08% 325 13.6% ND ND ND ND
Monodelphis 
domestica
32690 2369 7.25% 661 27.9% ND ND ND ND
Gallus gallus 24168 1519 6.29% 413 27.19% ND ND ND ND
Xenopus 
tropicalis
28324 2383 8.41% 931 39.07% ND ND ND ND
Fugu rubripes 22102 1612 7.29% 627 38.9% ND ND ND ND
Danio rerio 36065 3312 9.18% 1224 36.96% ND ND ND ND
Ciona 
intestinalis
20000 1452 7.26% 670 46.14% ND ND ND ND
Caenorhabditis 
elegans
26439 918 3.47% 117 12.75% ND ND ND ND
Drosophila 
melanogaster
19789 1071 5.41% 120 11.2% ND ND ND ND
Conflict 2 Number of 
proteins
Identified as 
containing an extra- 
and an intracellular 
domain
Percentage Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True 
errors
Percentage*
Homo sapiens 48403 101 0.21% 18 17.82% 18 17.82% 0 0.00%
Mus musculus 31302 50 0.16% 4 8.00% 4 8.00% 0 0.00%
Rattus 
norvegicus
33745 67 0.2% 12 17.91% 10 14.93% 2 2.99%
Monodelphis 
domestica
32690 101 0.31% 25 24.75% 9 8.91% 16 15.84%
Gallus gallus 24168 45 0.19% 5 11.11% 4 8.89% 1 2.22%
Xenopus 
tropicalis
28324 57 0.2% 11 19.3% 5 8.77% 6 10.53%
Fugu rubripes 22102 58 0.26% 19 32.76% 12 20.69% 7 12.07%
Danio rerio 36065 75 0.21% 8 10.67% 7 9.33% 1 1.33%
Ciona 
intestinalis
20000 29 0.15% 2 6.90% 2 6.90% 0 0.00%
Caenorhabditis 
elegans
26439 12 0.05% 1 8.33% 1 8.33% 0 0.00%
Drosophila 
melanogaster
19789 16 0.08% 1 6.25% 1 6.25% 0 0.00%
Conflict 3 Number of 
proteins
Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True 
errors
Percentage*
Homo sapiens 48403 1 0.002% 0 0.00% 1 0.002%
Mus musculus 31302 3 0.01% 0 0.00% 3 0.01%
Rattus 
norvegicus
33745 3 0.01% 0 0.00% 3 0.01%
Monodelphis 
domestica
32690 0 0.00% 0 0.00% 0 0.00%
Gallus gallus 24168 1 0.004% 0 0.00% 1 0.004%
Xenopus 
tropicalis
28324 0 0.00% 0 0.00% 0 0.00%
Fugu rubripes 22102 2 0.01% 0 0.00% 2 0.01%
Danio rerio 36065 0 0.00% 0 0.00% 0 0.00%BMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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Errors of TrEMBL entries are not only due to the incom-
pleteness of cDNAs; transcripts formed through aberrant
splicing and chimeric transcripts may also contribute to
errors in this database. Interestingly, there are numerous
human TrEMBL entries that are chimeric (0.33%), differ-
ent segments of the predicted protein sequences being
encoded by different genes located on different chromo-
somes. A large proportion (43.6%) of these chimeric
entries are annotated as resulting from the fusion of genes
located on different chromosomes through chromosomal
translocation in a cancer cell line, 7.6% have no such
annotation although the corresponding cDNAs were
cloned from cancer tissues. It should be pointed out, how-
ever, that there are many chimeric proteins in UniProtKB
derived from cDNAs that were cloned from apparently
normal tissues (36.6%), suggesting that chimera forma-
tion is more general than previously thought. For exam-
ple, the cDNA of the hypothetical protein FLJ20227
[TrEMBL:Q9NXI4], cloned from colon mucosa, is a chi-
mera of two genes located on chromosome 11 and chro-
mosome 2. The N-terminal part of the protein is derived
from the gene encoding the PR domain zinc finger protein
10 (PRD10_HUMAN) [Swiss-Prot:Q9NQV6], the C-ter-
minal part is derived from the gene encoding the liver
form of Fatty acid-binding protein (FABPL_HUMAN)
[Swiss-Prot:P07148] (see Figure 5). Another factor that
increased the number of human chimeric proteins in
TrEMBL is that the biotechnology industry has contrib-
uted numerous synthetic (chimeric) human constructs to
the TrEMBL database (5.8%).
It is also noteworthy that the rate of chimeras is much
higher in the case of zebrafish sequences (1.97%) than in
the case of other vertebrates. As discussed in Additional
file 1 [see Additional file 1], the most likely explanation
for this observation is that the chromosomal assignment
of contigs encoding these zebrafish genes may not be cor-
rect: contigs carrying different fragments of a zebrafish
Ciona 
intestinalis
20000 0 0.00% 0 0.00% 0 0.00%
Caenorhabditis 
elegans
26439 0 0.00% 0 0.00% 0 0.00%
Drosophila 
melanogaster
19789 0 0.00% 0 0.00% 0 0.00%
Conflict 4 Number of 
proteins
Proteins containing 
domains suitable for 
the study of domain 
integrity
Percentage Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True 
errors
Percentage*
Homo sapiens 48403 16681 34.46% 850 5.1% ND ND ND ND
Mus musculus 31302 9955 31.80% 306 3.07% ND ND ND ND
Rattus 
norvegicus
33745 11826 35.05% 474 4.01% ND ND ND ND
Monodelphis 
domestica
32690 11847 36.24% 381 3.22% ND ND ND ND
Gallus gallus 24168 6261 25.91% 383 6.12% ND ND ND ND
Xenopus 
tropicalis
28324 6733 23.78% 318 4.72% ND ND ND ND
Fugu rubripes 22102 5464 24.72% 278 5.09% ND ND ND ND
Danio rerio 36065 9402 26.07% 591 6.29% ND ND ND ND
Ciona 
intestinalis
20000 2114 10.57% 147 6.95% ND ND ND ND
Caenorhabditis 
elegans
26439 3039 11.49% 86 2.83% ND ND ND ND
Drosophila 
melanogaster
19789 3341 16.88% 58 1.74% ND ND ND ND
Conflict 5 Number of 
proteins
Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True 
errors
Percentage*
Homo sapiens 48403 0 0.00% 0 0.00% 0 0.00%
Danio rerio 36065 9 0.02% 7 0.02% 2 0.01%
*Values for suspicious, false positive and true positive sequences are expressed as percentage of the proteins relevant for the given conflict.
ND – not determined
Table 3: MisPred analysis of EnsEMBL entries (Continued)BMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
Page 13 of 26
(page number not for citation purposes)
Table 4: MisPred analysis of NCBI's GNOMON-predicted proteins
NCBI/GNOMON
Conflict 1 Number of 
proteins
Identified as 
containing an 
extracellular 
domain
Percentage Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True errors Percentage*
Homo 
sapiens
10125 287 2.83% 93 32.4% ND ND ND ND
Monodelphis 
domestica
20110 1293 6.43% 253 19.57% ND ND ND ND
Gallus gallus 14816 909 6.14% 246 27.06% ND ND ND ND
Danio rerio 25356 2108 8.31% 562 26.66% ND ND ND ND
Conflict 2 Number of 
proteins
Identified as 
containing an 
extra- and an 
intracellular 
domain
Percentage Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True errors Percentage*
Homo 
sapiens
10125 4 0.04% 0 0% 0 0.00% 0 0.00%
Monodelphis 
domestica
20110 32 0.16% 6 18.75% 3 9.38% 3 9.38%
Gallus gallus 14816 22 0.15% 5 22.73% 3 13.64% 2 9.09%
Danio rerio 25356 31 0.12% 11 35.48% 5 16.13% 6 19.35%
Conflict 3 Number of 
proteins
Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True errors Percentage*
Homo 
sapiens
10125 0 0.00% 0 0.00% 0 0.00%
Monodelphis 
domestica
20110 2 0.01% 0 0.00% 2 0.01%
Gallus gallus 14816 2 0.01% 1 0.01% 1 0.01%
Danio rerio 25356 7 0.03% 3 0.01% 4 0.02%
Conflict 4 Number of 
proteins
Proteins 
containing 
domains suitable 
for the study of 
domain integrity
Percentage Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True errors Percentage*
Homo 
sapiens
10125 1632 16.12% 255 15.63% ND ND ND ND
Monodelphis 
domestica
20110 6224 30.95% 111 1.78% ND ND ND ND
Gallus gallus 14816 3564 24.06% 370 10.38% ND ND ND ND
Danio rerio 25356 4387 17.31% 385 8.78% ND ND ND ND
Conflict 5 Number of 
proteins
Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True errors Percentage*
Homo 
sapiens
10125 1 0.01% 0 0.00% 1 0.01%
Danio rerio 25356 25 0.10% 24 0.09% 1 0.004%
*Values for suspicious, false positive and true positive sequences are expressed as percentage of the proteins relevant for the given conflict.
ND – not determinedBMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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gene may be incorrectly assigned to different chromo-
somes.
MisPred routines for Conflict 2 and Conflict 3 identified
no TrEMBL entries as erroneous. This is primarily due to
the fact that sequences predicted in silico (that could miss
internal transmembrane segments separating extracellular
and cytoplasmic domains or fuse tandem genes) are
absent from this section of UniProtKB.
MisPred analysis of the EnsEMBL database and the 
GNOMON-predicted proteins of the NCBI database
Table 3 and Table 4 summarize the results of the analysis
of the EnsEMBL database and the GNOMON-predicted
proteins of the NCBI database for the various species and
the five different MisPred routines (for details [see Addi-
tional file 1]).
As illustrated in Tables 3 and 4, a relatively high propor-
tion of EnsEMBL and GNOMON-predicted entries are
detected by the routine for Conflict 1 as suspicious (rang-
ing from 8 to 46% for EnsEMBL and 20 to 32% for NCBI
entries containing extracellular domains). The most likely
explanation for this is that in a large proportion of
secreted vertebrate proteins the signal peptide is encoded
by an exon separated by a long intron from the down-
stream exon [23]. Low sequence conservation of signal
peptides and low transcript- and EST-coverage of 5' parts
of protein-coding genes explain why finding short exons
encoding just the signal peptides has a rather low rate of
success in the case of vertebrate genomes. This problem is
less serious in the case of intron-poor genomes, such as
those of Caenorhabditis elegans or Drosophila melanogaster
since their signal peptides are less likely to be encoded by
short, distinct exons [24]; this is reflected in a lower pro-
portion of suspicious proteins in the case of EnsEMBL
entries of these species. Furthermore, worm and fruitfly
were the first metazoan organisms whose genome
sequences were determined [25,26] and genome annota-
tion efforts of nearly a decade have significantly improved
the quality of gene predictions.
Very few erroneous EnsEMBL and GNOMON-predicted
sequences were detected by the routine for Conflict 2. The
explanation for the low rate of this type of error is that –
unlike signal peptide segments – transmembrane helices
are usually encoded by longer exons that also encode
other conserved parts of transmembrane proteins, facili-
tating their detection. Another factor that facilitates detec-
tion of exons of transmembrane regions is that they are
more likely to be located in the middle or 3' parts of genes
whose transcript- and EST-coverage is relatively high. The
true positives for Conflict 2 were found to be of two major
types:
(1) The predicted protein lacks transmembrane helices
since the corresponding region of the gene is mispre-
dicted. For example, ENSXETP00000040601 [EnsEMBL:
ENSXETP00000040601], which corresponds to the frog
ortholog of Ephrin receptor A7, lacks a typical transmem-
brane helix between its extracellular and cytoplasmic
domains; the missing transmembrane sequence could be
corrected using frog EST sequences (Figure 6). Detailed
analysis of this group of true positives (vertebrate EPH
receptor tyrosine kinases, Tie-2 receptor tyrosine kinases,
skeletal muscle receptor tyrosine kinases, receptor-type
tyrosine-protein phosphatases, Notch proteins, etc.)
revealed that the regions containing their transmembrane
helices are encoded by relatively short exons distinct from
those encoding conserved extracellular and cytoplasmic
domains [27], making it difficult to find these exons.
(2) The gene was mispredicted by in silico fusion of dis-
tinct, tandem genes encoding extracellular and cytoplas-
mic proteins. Several examples of this type of error were
found among Fugu rubripes proteins, but not in the case of
other organisms, including zebrafish. A possible explana-
tion for this observation is that the intergenic distance is
significantly shorter in the compact genome of pufferfish
than in the case of other vertebrate genomes [28], increas-
ing the chance of in silico fusion of tandem genes.
MisPred routine for Conflict 3 detected very few errors in
predicted proteins. Analyses of these sequences have
revealed that they arose as a result of in silico fusion of two
or more distinct, tandem genes encoding extracellular and
nuclear proteins. Interestingly, proteins containing extra-
cellular Pentaxin and nuclear Chromo domains were
found among human, mouse, rat and chicken EnsEMBL
proteins. There are several interpretations for their occur-
rence in different warm-blooded animals. One possible
explanation is that since the constituent genes are closely
linked in all these species, gene-prediction erroneously
fused these otherwise independent genes. An alternative
explanation is that these genes truly give rise to novel tran-
scripts and proteins in which nuclear Chromo domains
are fused to extracellular Pentaxin domains. In other
words, nuclear Chromo domains can co-occur with the
extracellular Pentaxin domains, either because the
Chromo domain is not an obligatory nuclear domain or
the Pentaxin domain is not an obligatory extracellular
domain. It is noteworthy in this respect that Chen and
Bixby [29,30] have cloned three mouse variants of neuro-
nal pentraxin with Chromo domain (Q6TLW1_MOUSE,
Q6TLW0_MOUSE, Q6TKP2_MOUSE) [Swiss-
Prot:Q6TLW1, Q6TLW0, Q6TKP2] but none of them have
signal peptides suggesting that, unlike the major products
of the neuronal pentraxin genes, they are not secreted. It is
still possible, however, that the fusion proteins encoded
by chimeric transcripts are abnormal in the sense that theyBMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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Error detected by MisPred routine for Conflict 2 Figure 6
Error detected by MisPred routine for Conflict 2. ENSXETP00000040601 of Xenopus tropicalis corresponds to the frog 
ortholog of Ephrin receptor A7, but lacks a typical transmembrane helix between its extracellular FN3 and cytoplasmic Pkinase 
domains. The mispredicted sequence was corrected by identifying the missing transmembrane sequence using frog EST 
sequences such as EL820950 [GenBank:EL820950]. The alignment shows the regions containing the transmembrane helices of 
Gallus gallus Ephrin receptor A7 [RefSeq:NP_990414], ENSXETP00000040601 and ENSXETP00000040601_corrected. The 
predicted transmembrane helices of NP_990414 and ENSXETP00000040601_corrected are in red and underlined, the mispre-
dicted region of ENSXETP00000040601 is in italics.
                              401                                            450 
ensxetp00000040601_corrected  SIVDLVAHANYTFEVEAVNGVSDLSRSQRLFAAVSVTTGQAAPSQVSGVM
                   np_990414  TVMDLLAHANYTFEVEAVNGVSDLSRSQRLFAAVSITTGQAAPSQVSGVM
          ensxetp00000040601  SIVDLVAHANYTFEVEAVNGVSDLSRSQRLFAAVSVTTGQAAPSQVSGVM
                              451                                            500 
ensxetp00000040601_corrected  KERVLQRAVDLSWQEPEHPNGVITEYEIKYYEKDQRERTYSTLKTKSTSV
                   np_990414  KERVLQRSVELSWQEPEHPNGVITEYEIKYYEKDQRERTYSTVKTKSTSA
          ensxetp00000040601  KERVLQRAVDLSWQEPEHPNGVITEYEIKYYEKDQRERTYSTLKTKSTSV
                              501                                            550 
ensxetp00000040601_corrected  SINNLRPGTAYIFQIRAFTAAGYGMYSPRLDVSTLEEATATAVSTEQNPV
                   np_990414  SINNLKPGTVYVFQIRAFTAAGYGNYSPRLDVATLEEATATAVSSEQNPV
          ensxetp00000040601  SINNLRPGTAYIFQIRAFTAAGYGMYSPRLDVSTLEEATVYYIFACSYCI  
                              551                                            600 
ensxetp00000040601_corrected IIIAVVAVAGTIILVFMVFGFIIGRRHCGYSKA..DQEGDEELYFHC...
                   np_990414 IIIAVVAVAGTIILVFMVFGFIIGRRHCGYSKA..DQEGDEELYFHF...
          ensxetp00000040601 AYI.MGSQSSLLLCLQIALQLLINSSSLYYTAALCDLNYNKSLKMHFPSG  
                              601                                            650 
ensxetp00000040601_corrected  ......TKTYIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVC
                   np_990414  ..KFPGTKTYIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVC
          ensxetp00000040601 LVKFPGTKTYIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVC
                              651                                            700 
ensxetp00000040601_corrected  SGRLKLPGKRDVPVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE
                   np_990414  SGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE
          ensxetp00000040601  SGRLKLPGKRDVPVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE
                              701                                            750 
ensxetp00000040601_corrected  GVVTRGKPVMIVIEFMENGALDAFLRKLDGQFTVIQLVGMLRGIAAGMRY
                   np_990414  GVVTRGKPVMIVIEYMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRY
          ensxetp00000040601  GVVTRGKPVMIVIEFMENGALDAFLRKLDGQFTVIQLVGMLRGIAAGMRY
                              751                                            800 
ensxetp00000040601_corrected  LADMGYVHRDLAARNILVNSNLVCKVSDFGLSRIIEDDPDAVYTTTQGGK
                   np_990414  LADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTT.GGK
          ensxetp00000040601  LADMGYVHRDLAARNILVNSNLVCKVSDFGLSRIIEDDPDAVYTTTQGGK
                              801                                            850 
ensxetp00000040601_corrected  IPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK
                   np_990414  IPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK
          ensxetp00000040601  IPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK BMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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are non-viable. It is important to point out that such chi-
meric transcripts of neuronal pentraxin are very rare, or
absent, as revealed by blast searches of EST databases. The
fact that the rate of such errors is highest in the case of
Fugu rubripes may be partly due to the short intergenic dis-
tance in the compact pufferfish genome.
MisPred routine for Conflict 4 detected a large number of
erroneous proteins both among EnsEMBL entries (1.74–
6.95%) and among GNOMON-predicted entries (1.78–
15.63%) containing members of Pfam-A domain families
suitable for the study of domain integrity. The relatively
high rate of erroneous insertion or omission of exons
encoding parts of domains indicates that misprediction of
exons encoding Pfam-A domains is quite general.
No erroneous human EnsEMBL protein was detected by
the routine for Conflict 5, i.e. none of them were chimeras
of genes located on different chromosomes. This is not
surprising in view of the fact that chromosomal assembly
of human genomic contigs is reliable therefore EnsEMBL
is exempt from the error of trans-chromosomal prediction
of human genes. MisPred analysis of the Homo sapiens
GNOMON-predicted entries has identified only one
sequence, XP_001128605 [RefSeq:XP_001128605], as a
chimera of genomic regions located on chromosomes 2
and 7. Note that in the NCBI database XP_001128605 has
been replaced recently by the nonchimeric
NP_001035225 [RefSeq: NP_001035225], encoded on
chromosome 7. In contrast with this, several zebrafish
entries were identified as suspicious by the MisPred rou-
tine for Conflict 5, an observation best explained by errors
in the chromosomal assignment and assembly of
zebrafish contigs. For example, ENSDARP00000056920
[EnsEMBL: ENSDARP00000056920] aligns over its entire
length with mammalian Casein kinase I isoform gamma-
2 proteins, but it is encoded by contigs assigned to chro-
mosomes 2 and 8. XP_001345102 [RefSeq:
XP_001345102] corresponds to a fragment of the
zebrafish ortholog of ephrin receptor EPHA3, it aligns
over its entire length with these receptors, but it is
encoded by contigs assigned to chromosome 12 and 25.
Incorrect assembly of contigs may lead to the in silico
fusion of regions located on different chromosomes. For
example, the major part of ENSDARP00000077525
[EnsEMBL:ENSDARP00000077525], encoded on chro-
mosome 7, is homologous with mammalian Solute car-
rier organic anion transporter family member 3A1
proteins, but an unrelated N-terminal extension of
ENSDARP00000077525 is encoded on chromosome 11.
XP_001345729 [RefSeq: XP_001345729], a zebrafish pro-
tein annotated as similar to TRAF interacting protein is a
chimera of traf-interacting protein and plasminogen
related growth factor receptor 3.
In summary, GNOMON-predicted sequences and
EnsEMBL sequences are quite similar inasmuch as simi-
larly high proportion of suspicious proteins can be
detected by Conflict 1 and Conflict 4 and fewer errors are
detected by Conflict 2, Conflict 3 and Conflict 5 (see
Tables 3 and 4). Despite these similarities, there are some
differences. For example, in the case of Conflict 2 several
EnsEMBL sequences were erroneous because the regions
corresponding to their transmembrane helices were mis-
predicted, whereas this type of error was not found among
the GNOMON-predicted sequences. In principle, such
differences may reflect differences in the performance of
the two gene prediction pipelines or differences in the
gene populations covered by the two databases. It should
also be pointed out that EnsEMBL is a comprehensive
source of known genes and genes predicted with GeneW-
ise [31], as well as the corresponding transcripts and pro-
teins whereas in the NCBI database transcripts/proteins
predicted by GNOMON are distinguished from those of
known transcripts/proteins by unique (XM_ or XP_) iden-
tifiers.
To permit a more direct comparison of the performance of
the two gene prediction pipelines we have compared the
results of MisPred analyses only for those protein-coding
genes for which both EnsEMBL and GNOMON have at
least one prediction (see Table 5). Comparison of the two
datasets confirmed that the two gene prediction pipelines
are similar inasmuch as they suffer primarily from errors
detectable by MisPred routines for Conflict 1 and Conflict
4, whereas the rates of errors detectable by routines for
Conflicts 2, 3 and 5 are very low. Nevertheless, there are
minor differences between the EnsEMBL and NCBI gene
prediction pipelines: EnsEMBL is more likely to fail in the
identification of exons encoding transmembrane helices,
whereas NCBI's GNOMON appears to be more prone to
fuse tandem genes in silico (for details of these analyses
[see Additional file 1]).
MisPred analysis of GENCODE sequences
The ENCODE (ENCyclopedia Of DNA Elements) Project
aims to identify all functional elements in the human
genome sequence. The pilot phase of the project is
focused on specified 30 megabases (approximately 1%) of
the human genome sequence [32]. GENCODE is a sub-
project of ENCODE; its overall goal is to identify all pro-
tein-coding genes in the regions of the human genome
selected within the ENCODE project.
MisPred analysis of the 1097 GENCODE peptides with
the routine for Conflict 1 identified one peptide [GEN-
CODE:AC110015.1-002] as containing an extracellular
(Cadherin) domain but lacking signal peptide and trans-
membrane segments. Blast searches revealed that
AC110015.1-002 corresponds to the N-terminal part ofBMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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Table 5: MisPred analysis of human genes predicted by the EnsEMBL and NCBI's GNOMON pipelines
EnsEMBL
Conflict 1 Number of 
proteins
Identified as 
containing an 
extracellular 
domain
Percentage Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True errors Percentage*
Homo 
sapiens
2772 147 5.3% 23 15.65% ND ND ND ND
Monodelphis 
domestica
10519 680 6.46% 137 20.15% ND ND ND ND
Gallus gallus 6139 345 5.62% 113 32.75% ND ND ND ND
Danio rerio 10289 860 8.36% 317 36.86% ND ND ND ND
Conflict 2 Number of 
proteins
Identified as 
containing an 
extra- and an 
intracellular 
domain
Percentage Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True errors Percentage*
Homo 
sapiens
2772 1 0.04% 0 0.00% 0 0.00% 0 0.00%
Monodelphis 
domestica
10519 10 0.1% 0 0.00% 0 0.00% 0 0.00%
Gallus gallus 6139 2 0.03% 0 0.00% 0 0.00% 0 0.00%
Danio rerio 10289 20 0.19% 5 25% 4 20% 1 5%
Conflict 3 Number of 
proteins
Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True errors Percentage*
Homo 
sapiens
2772 0 0.00% 0 0.00% 0 0.00%
Monodelphis 
domestica
10519 0 0.00% 0 0.00% 0 0.00%
Gallus gallus 6139 0 0.00% 0 0.00% 0 0.00%
Danio rerio 10289 0 0.00% 0 0.00% 0 0.00%
Conflict 4 Number of 
proteins
Proteins 
containing 
domains 
suitable for 
the study of 
domain 
integrity
Percentage Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True errors Percentage*
Homo 
sapiens
2772 722 26.05% 48 6.65% ND ND ND ND
Monodelphis 
domestica
10519 3726 35.42% 119 3.19% ND ND ND ND
Gallus gallus 6139 1640 26.72% 159 9.70% ND ND ND ND
Danio rerio 10289 2565 24.93% 197 7.68% ND ND ND ND
Conflict 5 Number of 
proteins
Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True errors Percentage*
Homo 
sapiens
2772 0 0.00% 0 0.00% 0 0.00%
Danio rerio 10289 0 0.00% 0 0.00% 0 0.00%BMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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NCBI/GNOMON
Conflict 1 Number of 
proteins
Identified as 
containing an 
extracellular 
domain
Percentage Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True errors Percentage*
Homo 
sapiens
3012 139 4.61% 32 23.02% ND ND ND ND
Monodelphis 
domestica
9703 642 6.62% 112 17.45% ND ND ND ND
Gallus gallus 5604 310 5.53% 88 28.39% ND ND ND ND
Danio rerio 8905 742 8.33% 158 21.29% ND ND ND ND
Conflict 2 Number of 
proteins
Identified as 
containing an 
extra- and an 
intracellular 
domain
Percentage Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True errors Percentage*
Homo 
sapiens
3012 2 0.07% 0 0% 0 0.00% 0 0.00%
Monodelphis 
domestica
9703 17 0.18% 4 23.53% 2 11.76% 2 11.76%
Gallus gallus 5604 3 0.05% 1 33.33% 1 33.33% 0 0.00%
Danio rerio 8905 16 0.18% 6 37.5% 4 25% 2 12.5%
Conflict 3 Number of 
proteins
Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True errors Percentage*
Homo 
sapiens
3012 0 0.00% 0 0.00% 0 0.00%
Monodelphis 
domestica
9703 1 0.01% 0 0.00% 1 0.01%
Gallus gallus 5604 0 0.00% 0 0.00% 0 0.00%
Danio rerio 8905 2 0.02% 1 0.01% 1 0.01%
Conflict 4 Number of 
proteins
Proteins 
containing 
domains 
suitable for 
the study of 
domain 
integrity
Percentage Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True errors Percentage*
Homo 
sapiens
3012 792 26.3% 41 5.18% ND ND ND ND
Monodelphis 
domestica
9703 3420 35.25% 39 1.14% ND ND ND ND
Gallus gallus 5604 1500 26.77% 208 13.87% ND ND ND ND
Danio rerio 8905 2059 23.12% 300 14.57% ND ND ND ND
Conflict 5 Number of 
proteins
Identified as 
suspicious by 
MisPred
Percentage* False 
Positives
Percentage* True errors Percentage*
Homo 
sapiens
3012 1 0.03% 0 0.00% 1 0.03%
Danio rerio 8905 5 0.06% 5 0.06% 0 0.00%
*Values for suspicious, false positive and true positive sequences are expressed as percentage of the proteins relevant for the given conflict.
ND – not determined.
The data refer to human genes for which both gene prediction pipelines generated at least one gene model.
Table 5: MisPred analysis of human genes predicted by the EnsEMBL and NCBI's GNOMON pipelines (Continued)BMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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CADH2_HUMAN [Swiss-Prot:P19022] but, due to alter-
native splicing, it lacks the N-terminal secretory signal
peptide. It seems unlikely that this transcript encodes a
viable protein since – in the absence of a secretory signal
peptide – it may not be transported into the extracytoplas-
mic space.
MisPred analysis of the GENCODE peptides for Conflict 4
identified 67 (6.1% of the total) as containing an abnor-
mally short or abnormally long Pfam-A domain. In the
majority of cases the deviant domains are N-terminally or
C-terminally truncated simply as a consequence of the
incompleteness of the transcripts. Nevertheless, we identi-
fied several cases where the domain deviates from normal
size as a result of alternative splicing [33].
Examples include AC015691.9-002 [GEN-
CODE:AC015691.9-002] (corresponding to
TRIM6_HUMAN [Swiss-Prot:Q9C030]), RP11-247A12.5-
001 [GENCODE:RP11-247A12.5-001] (corresponding to
CACP_HUMAN [Swiss-Prot:P43155]), XX-
FW83563B9.3-006 [GENCODE:XX-FW83563B9.3-006]
(corresponding to TAZ_HUMAN [Swiss-Prot:Q16635]),
AP006216.3-003 [GENCODE:AP006216.3-003] (corre-
sponding to ZPR1_HUMAN [Swiss-Prot:O75312]), RP11-
298J23.1-003 [GENCODE:RP11-298J23.1-003] (corre-
sponding to PEPC_HUMAN [Swiss-Prot:P20142]) and
RP11-247A12.4-008 [GENCODE:RP11-247A12.4-008]
(corresponding to PTPA_HUMAN [Swiss-Prot:Q15257])
containing domains that deviate from normal size as a
result of alternative splicing. Structural and functional
analyses of the putative proteins encoded by these alterna-
tively spliced transcripts suggest that, in many cases, the
deviation from normal domain-size may not be compati-
ble with the viability of these proteins, suggesting that the
transcripts arose through aberrant splicing [33].
MisPred analysis of the GENCODE peptides for Conflicts
2, 3 and 5 did not identify suspicious sequences.
Conclusion
MisPred may identify proteins as suspicious for three dif-
ferent reasons.
MisPred may identify normal, viable proteins as suspicious 
due to errors of genomic data and limitations of the 
bioinformatic tools incorporated in MisPred
MisPred analyses of predicted zebrafish sequences illus-
trate the point that a 'correct' protein sequence may be
suspected to be a chimera encoded by two or more genes
located on different chromosomes if the assembly of the
contigs is incorrect.
Errors in the bioinformatic identification of sequence fea-
tures used to detect the various types of Conflicts may
raise unjustified doubts about the viability of some pro-
tein sequences. For example, this type of error is encoun-
tered in the case of some secreted or transmembrane
proteins (identified as such by the presence of obligatory
extracellular domains) whose atypical signal peptides or
transmembrane helices are not detected with high confi-
dence by the signal peptide or transmembrane helix pre-
diction programs incorporated into the MisPred routines.
Similarly, the hmmpfam program may on occasion iden-
tify marker domains erroneously, leading to the incorrect
prediction of the subcellular localization of a protein
domain.
Analyses of the benchmark Swiss-Prot proteins, however,
have revealed that the false positive rates of the MisPred
routines are lower than 0.001%. For details of the specifi-
city analyses see Materials and methods.
MisPred may identify normal, viable proteins as suspicious 
due to limitations of the dogmas on which MisPred 
routines are based
A survey of the results of MisPred analyses has revealed
that there are some exceptions to the dogmas on which
the MisPred approach is based. For example, some
secreted proteins may truly lack secretory signal peptides
since they are subject to leaderless protein secretion [22],
some predominantly extracellular, cytoplasmic or nuclear
Pfam-A domain families are not always restricted to a sin-
gle subcellular location and thus may be multilocale etc.
Similarly, it cannot be excluded at present that transchro-
mosomal chimeras can be formed and may have normal
physiological functions [16]. Nevertheless, the fact that
MisPred analyses of protein sequences of the Swiss-Prot
database identified very few such exceptions indicates that
the dogmas of MisPred are generally valid.
MisPred may identify truly abnormal, nonviable proteins
MisPred analyses of Swiss-Prot, TrEMBL, EnsEMBL, NCBI
and GENCODE sequences identified numerous hypothet-
ical protein sequences that are likely to be nonviable since
they violate some of the basic dogmas about viable pro-
teins.
For example, analysis of the TrEMBL sequences revealed
that incomplete or abnormal hypothetical proteins trans-
lated in silico from incomplete cDNAs or aberrant tran-
scripts are quite abundant in this database. A recent study
[33] has also revealed that alternative splicing frequently
generates transcripts that encode nonviable proteins due
to violation of domain integrity, loss of signal peptides,
etc.
Interestingly, there are also numerous chimeric entries in
the TrEMBL database, a large proportion of which are
derived from normal tissues. There are several mecha-BMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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nisms for the creation of chimeric proteins. Unequal
crossing over resulting in the fusion of parts of tandem
genes and chromosomal translocation resulting in the
fusion of genes located on different chromosomes are the
two best documented mechanisms for the creation of chi-
meric genes and proteins. Recent studies have convinc-
ingly shown that transcription of tandem genes into a
single RNA sequence and translation of the chimeric
mRNA into a chimeric protein [34,35] is also a major
mechanism for the creation of chimeric proteins.
Unneberg and Claverie [36] have recently suggested that
chimeric proteins might also be formed through tran-
schromosomal transcription, i.e. if genes located on dif-
ferent chromosomes are expressed in the same
"transcription factory" they may give rise to chimeric tran-
scripts.
It should be pointed out that the relatively high propor-
tion of incomplete and abnormal entries in TrEMBL also
has an impact on gene prediction. Since most gene predic-
tion pipelines rely on extrinsic information [5] such as
those provided by TrEMBL, some of the errors of TrEMBL
may be inherited by the databases of predicted genes. It is
noteworthy in this respect that the majority of errors of
EnsEMBL and GNOMON-predicted sequences can be
detected with the use of Conflict 1 and Conflict 4, proba-
bly reflecting the fact the TrEMBL sequences also suffer
from the same types of errors. The relatively high propor-
tion of transchromosomal chimeric sequences among
TrEMBL entries, however, does not have a major impact
on gene prediction, provided that contig assembly is
unambiguous.
Sequences not detected by MisPred do not necessarily 
correspond to normal, viable proteins
Although MisPred identifies many suspicious sequences,
it should be emphasized that the routines detect only a
fraction of the truly erroneous sequences. First, the Mis-
Pred routines described in this manuscript exploit only
five of the various dogmas about viable proteins. Second,
only a fraction of proteins contains members of well-char-
acterized Pfam-A domain families, i.e. families on which
the routines for Conflicts 1, 2, 3 and 4 rely. Third, the
number of suspicious sequences identified by Conflicts 1,
2 or 3 significantly underestimates the actual number of
sequences that may be affected by these types of errors
since we used only validated, obligatory extracellular,
cytoplasmic and nuclear Pfam-A domain families to pre-
dict the subcellular localization of proteins and did not
include numerous extracellular, cytoplasmic or nuclear
domain families the members of which may also occur in
other subcellular compartments. Fourth, in the case of
Conflict 4 MisPred uses a high cut-off value: a domain is
judged to be nonviable only if its Pfam-A domain deviates
from normal size by at least 40% in length. For details of
the sensitivity analyses see Materials and methods.
Summary
Recent studies have shown that a significant proportion of
eukaryotic genes may be mispredicted at the transcript
level [5,6]. Since the MisPred routines described here are
able to detect many of these errors and may aid the correc-
tion of these errors we suggest that the MisPred approach
may significantly improve the quality of protein sequence
data based on gene-predictions. In order to increase the
sensitivity of the approach we are currently developing
additional routines, based on the violation of other dog-
mas about proteins. The MisPred approach may also be
used as a discovery tool since it can also serve to explore
the limitations of the dogmas on which the various Mis-
Pred routines are based.
Methods
Protein sequence data analyzed
Protein sequence databases
In the analysis of the Swiss-Prot section of the UniProtKB
we have included Metazoan species that have at least 1000
Swiss-Prot entries. The UniProtKB Swiss-Prot [37] entries
from UniProtKB Version 9.5 (January, 2007) were down-
loaded from http://www.expasy.uniprot.org/database/
download.shtml.
The UniProtKB TrEMBL [37] entries from UniProtKB Ver-
sion 10.5 (May, 2007) were downloaded from http://
www.expasy.uniprot.org/database/download.shtml.
The 1097 GENCODE protein sequences were obtained
from http://genome.imim.es/biosapiens/gencode/data
set/v2.2.html.
The protein sequences of the EnsEMBL database were
downloaded from the EnsEMBL website [38], release 41
(October, 2006), found at ftp://ftp.ensembl.org/pub/
release-41.
The NCBI's protein sequences of four species (Homo sapi-
ens, 15 September 2006, Monodelphis domestica, 06 March
2007, Gallus gallus, 30 November 2006, Danio rerio, March
2007), were obtained by downloading the relevant pro-
tein.fa.gz files from the NCBI Genome Data/Annotation
Projects website [39], found at ftp://ftp.ncbi.nih.gov/
genomes/. In order to analyze only the sequences pre-
dicted by GNOMON http://www.ncbi.nlm.nih.gov/
genome/guide/gnomon.html, an in-house program was
used to extract only GNOMON-predicted FASTA
sequences with 'XP_' identifiers.
Comparison of the EnsEMBL and NCBI/GNOMON gene predictions
In order to compare the reliability of the two gene predic-
tion pipelines, we analyzed the proportion of suspicious
sequences among predicted proteins represented in both
EnsEMBL and NCBI's GNOMON-predicted section fromBMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
Page 21 of 26
(page number not for citation purposes)
four evolutionarily distant species (Homo sapiens, Mono-
delphis domestica, Gallus gallus and Danio rerio).
To identify the number of genes in each species for which
both GNOMON and EnsEMBL have at least one predicted
protein sequence, blastp [40] searches were performed on
the GNOMON-predicted sequences using EnsEMBL
sequences as queries. Protein sequences that displayed
100% identity over at least 25 amino acid residue-long
ungapped segments were considered to be encoded by the
same gene. The blastp standalone program, version
2.2.13, was obtained from: ftp://ftp.ncbi.nih.gov/blast/
executables/release/2.2.13.
Prediction of the subcellular localization of proteins by the 
presence of obligatory extracellular, cytoplasmic or 
nuclear protein-domains
Recent studies have revealed that there is a strong correla-
tion between the domain-composition of proteins and
their subcellular location: some domains are restricted to
proteins targeted to the extracellular space, others occur
only in proteins present in the cytoplasmic space, whilst
others are restricted to proteins of the nucleus [17,18].
Transmembrane multidomain proteins are special in the
sense that obligatory extracellular and cytoplasmic
domains can legitimately co-occur in a single protein.
Accordingly, the presence of obligatory extracellular, cyto-
plasmic or nuclear domains in a protein may be used to
predict its subcellular localization, independent of the
detection of sorting signals.
Since domains are most likely to co-occur in multidomain
proteins if they belong to the same localization-category,
analysis of domain co-occurrence networks is useful for
the systematic assignment of domains to different subcel-
lular compartments [17,18]. Our domain co-occurrence
analyses of Metazoan UniProtKB entries have identified
166 obligatory extracellular, 115 obligatory cytoplasmic
and 126 obligatory nuclear Pfam-A domain families as
being restricted to the respective subcellular compart-
ment, the majority of which are also identified as such in
the SMART database http://smart.embl-heidelberg.de/
[see Additional files 3, 4 and 5], respectively. In the Mis-
Pred analyses described in the present work only these
obligatory extracellular or cytoplasmic or nuclear domain
families were used to predict subcellular localization.
Pfam-A domains that are known not to be restricted to a
particular cellular compartment, such as immunoglobu-
lin domains, fibronectin type III domains, von Wille-
brand factor type A domains (i.e. domains that are
'multilocale'), are not reliable predictors of subcellular
localization and thus they were not utilized in these anal-
yses.
The programs of the HMMER 2.3.2 software package were
used to detect obligatory extracellular, cytoplasmic and
nuclear Pfam-A domains. HMM databases of Pfam-A
domains were created by retrieving the HMMs of the
domains from the Pfam (Pfam_ls) HMM and the Pfam
fragment (Pfam_fs) HMM libraries [41]. The presence of
Pfam-A domains in protein sequences was detected by
searching the HMM databases against protein sequences
using the hmmpfam program using 0.00001 as per-
domain E-value threshold. We filtered the results for over-
lapping domain matches and the match with the lowest E-
value was accepted.
The Pfam HMM libraries (Release 20.0) were obtained
from ftp://ftp.sanger.ac.uk/pub/databases/Pfam/. The
HMMER software package was obtained from http://
hmmer.janelia.org/.
Detection of suspicious (incomplete, abnormal and 
mispredicted) proteins
Conflict 1: Conflict between the predicted subcellular localization of 
proteins and the absence of the corresponding sequence signals
Proteins containing obligatory extracellular Pfam-A
domains were analyzed by the PrediSi program [42] to
identify the presence of eukaryotic signal peptide
sequences (using 0.3 as threshold) and by the TMHMM
program [43] to detect the presence of transmembrane
helices. Protein sequences containing obligatory extracel-
lular domains but neither a signal peptide nor a trans-
membrane helix were identified as suspicious. The PrediSi
program was downloaded from http://www.predisi.de.
The TMHMM program was obtained from http://
www.cbs.dtu.dk/services/TMHMM.
Conflict 2: Presence of obligatory extracellular and cytoplasmic 
domains and the absence of transmembrane helices
Proteins containing both obligatory extracellular and
obligatory cytoplasmic Pfam-A domains were analyzed by
the TMHMM program to detect transmembrane helices.
Sequences, which contain both extra- and cytoplasmic
domains (i.e. putative transmembrane proteins), but do
not have a transmembrane helix were identified as suspi-
cious.
Conflict 3: Co-occurrence of extracellular and nuclear domains in a 
single protein
Protein sequences containing both obligatory extracellu-
lar and obligatory nuclear domains were identified as sus-
picious.
Conflict 4: Violation of domain integrity
In order to identify the Pfam-A domain families that have
a well-defined, conserved sequence length range, we
selected only those families whose members do not devi-
ate from the average size by more than 2 standard devia-
tion (SD) values in the high quality Swiss-Prot database
(version 48.9). Based on these criteria, about 90% of the
Pfam-A domain families present in Swiss-Prot proteinsBMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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proved to be suitable for the study of domain integrity.
The list of the Pfam-A families is deposited in Additional
file 6 [see Additional file 6]. We created databases of
human, vertebrate and metazoa+fungi Swiss-Prot domain
sequences belonging to the reliable Pfam-A families and
ran a blastp search with the current set of proteins as que-
ries against the appropriate reliable Swiss-Prot domain
sequences. We selected those partial domain matches
which share over 60% identity with the query sequence,
with an E-value < 1e-5, and differ by at least 40% in length.
The protein sequences containing these domains with
deviant lengths were identified as suspicious. For the
details of this method [see Additional file 1].
Conflict 5: Chimeric proteins encoded by two or more different genes 
located on different chromosomes
The protein sequences were matched to the genome of the
given species using the BLAT program [44]. We selected
matches with >95% identity over ≥ 15 amino acid residue
in length and in the case of overlapping matches (if the
overlap was >5 residues) we selected the longest match. To
eliminate problems encountered with genes encoded by
the mitochondrial genome [see Additional file 1] we used
an additional BLAT search and discarded those entries
which gave >90% match with the mitochondrial genome
over more than 90% of their length. Proteins were consid-
ered suspicious if two or more of their segments were
encoded on different chromosomes. The BLAT program
was obtained from http://genome-test.cse.ucsc.edu/
~kent/exe/. The following genome assemblies were used
in these analyses: Homo sapiens NCBI 36, Mar 2006; Mus
musculus NCBI 36, Febr 2006; Rattus rattus RGSC 3.4, Nov
2004; Gallus gallus WASHUC2, May 2006; Danio rerio Zv6,
Mar 2006;; Caenorhabditis elegans WS170, Jan 2007; Dro-
sophila melanogaster BDGP 5, Apr 2006.
Testing the specificity and sensitivity of MisPred methods
Specificity
To calculate the false positive rate (α) and specificity (1-α)
of MisPred from the equation α = FP/(FP+TN), we have
determined the number of false positives (FP) and true
negatives (TN) from the results obtained by application of
MisPred to Swiss-Prot entries. In these calculations FP
equals the number of entries that were identified with the
given method as suspicious, although they do not to vio-
late the given dogma. Considering that Swiss-Prot is a very
clean database, the entries not identified by MisPred as
suspicious were assumed to be true negatives (TN), i.e.
they do not violate the given dogma. Specificity was also
calculated by analyzing datasets obtained by mixing cor-
rect Swiss-Prot entries and erroneous sequences generated
from Swiss-Prot sequences (see below). The false positive
rates of the MisPred routines were calculated to be ≤
0.001, i.e. their specificity is very high (≥ 0.999).
Sensitivity
Since at the protein level the major types of errors of gene
prediction (failure to find a true exon, erroneous inclu-
sion of a false exon, misprediction of an exon, fusion of
exons of tandem genes etc.) are manifested as internal or
terminal deletions, internal insertions, terminal exten-
sions and fusions, we have generated datasets of
sequences from human Swiss-Prot entries to mimic these
errors.
To test the effect of terminal deletions, a group of datasets
was created through deletion of 50, 100, 150, 200 etc. res-
idues from their N-terminal end or their C-terminal end.
Another group of datasets were obtained by deleting the
second, third, fourth etc. 50 or 100 residue-segments of
the proteins to study the effect of internal deletions. Ter-
minal extensions or internal insertions were mimicked by
addition/insertion of 50 or 100 amino acid segments
(with random sequences and average amino acid compo-
sition) to the N-terminal and C-terminal end or after posi-
tions 50, 100, 150 etc. of these proteins. To mimic the
effect of fusions datasets were generated by fusing 5000
randomly selected entries to a different set of 5000 ran-
domly selected proteins.
Subsets of the above datasets were created to gain insight
into the factors that influence the sensitivity of the differ-
ent MisPred methods. The false negative rate (β) and sen-
sitivity (1-β) of MisPred were calculated from the
equation β = FN/(TP + FN). Since all entries in these data-
sets are erroneous (i.e. they differ from the correct
sequence), entries detected by MisPred as suspicious are
true positives (TP), whereas those not detected by MisPred
are false negatives (FN).
The MisPred routine for Conflict 1 detected only 4.5% of
the sequences from which the N-terminal 50 residues
(that might contain secretory signal peptide or signal-
anchor sequences) were removed. One major source of
such a low sensitivity is that only a fraction of proteins are
secreted or type II transmembrane proteins, the integrity
of which can be tested with this method. When we ana-
lyzed a dataset generated by N-terminal truncation of pro-
teins containing signal peptide or signal anchor sequences
but lacking transmembrane segments, sensitivity
increased to 33.1%. The reason why only about a third of
the erroneous proteins are detected by MisPred is that the
majority of these proteins does not contain an obligatory
extracellular Pfam-A domain and is thus 'invisible' to this
method. When we restricted MisPred analysis to errone-
ous entries generated from secreted and type II transmem-
brane proteins containing an obligatory extracellular
Pfam-A domain, sensitivity increased to 87.2%.BMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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Only a very small fraction (0.79%) of the proteins pos-
sessing transmembrane helices are detected as erroneous
by MisPred routine for Conflict 2 after removing their
transmembrane helices. This is due to the fact that few of
the transmembrane proteins contain both an obligatory
extracellular and an obligatory cytoplasmic Pfam-A
domain. If, however, we applied this method to erroneous
entries generated from transmembrane proteins contain-
ing both an obligatory extracellular and an obligatory
cytoplasmic Pfam-A domain, sensitivity increased to
83.7%.
The sensitivity of the MisPred routine for Conflict 3 was
found to be 1.06% when we applied it to chimeric pro-
teins generated by random fusion of proteins. Such a low
sensitivity is due to several factors. First, nuclear proteins
account for only ~14% of the entire proteome [45]. Sec-
ond, our analyses have shown that only 26.7% of the
nuclear proteins identified by Fink et al. [45] (2008) con-
tain obligatory nuclear domains [see Additional file 5].
Third, only a fraction of proteins contains an obligatory
extracellular Pfam-A domain. In harmony with this expla-
nation, the sensitivity of the MisPred routine for Conflict
3 was found to be 99.9% when we applied it to chimeric
proteins generated by fusion of human Swiss-Prot pro-
teins containing obligatory extracellular domains to pro-
teins containing obligatory nuclear domains.
The sensitivity of the MisPred routine for Conflict 4 was
found to depend on the extent of terminal truncation of
the protein sequences. Progressive truncation from the C-
terminal or N-terminal end increased the sensitivity to a
maximum of ~4% when ~250 residues were deleted, dele-
tion of longer segments did not further increase sensitiv-
ity. The explanation for this observation is that this type of
error becomes undetectable if the entire domain or the
major part of the domain is removed. Sensitivity was
found to be ~0.6% (or ~3%) in the case of internal dele-
tions of 50 residue (or 100 residue) segments, and ~0.1%
(or 4%) in the case of internal insertions of 50 (or 100)
residue-long segments with random amino acid
sequences, irrespective of the positions of the moving
window deletions or the insertions. Addition of such ran-
dom sequences to the N-terminal end, C-terminal end of
human Swiss-Prot entries did not generate errors detecta-
ble by MisPred routine for Conflict 4. The relatively low
sensitivity of the MisPred routine for Conflict 4 is due to
the fact that only a fraction of human Swiss-Prot proteins
contain a Pfam-A domain suitable for the detection of
domain size deviation (see Table 1). Another factor that
contributes to the low sensitivity of this approach is that a
protein is detected as erroneous only if its Pfam-A domain
deviates from normal size by at least 40% in length (see
above).
The sensitivity of the MisPred routine for Conflict 5 was
found to be very high (91.5%), when tested on artificial
chimeras generated by random fusion of human Swiss-
Prot proteins. Analysis of the few false negatives revealed
that some of the chimeric proteins were not detected
because the constituent proteins are encoded on the same
chromosome, in other cases the BLAT match was below
the 95% threshold. If we restricted the analyses to chime-
ras generated by fusion of genes encoded on different
chromosomes, sensitivity increased to 92.9%.
Resolution of Conflicts
In order to test whether a suspicious protein sequence
identified by one of the MisPred routines is truly errone-
ous (or a false positive) we subjected these sequences to
additional analyses. Such analyses were performed for all
suspicious Swiss-Prot entries identified by all five MisPred
routines as well as for all EnsEMBL, GNOMON-predicted
and human TrEMBL entries identified by MisPred rou-
tines for Conflicts 2, 3 and 5 (for details [see Additional
file 1]).
Sequences identified by MisPred routines for Conflict 1
and Conflict 2 as suspicious were analyzed by the SignalP
[46]http://www.cbs.dtu.dk/services/SignalP/ and Pho-
bius [47]http://phobius.cgb.ki.se/ programs to detect sig-
nal peptides and/or transmembrane helices potentially
missed by the PrediSi and/or the TMHMM programs.
To identify cases of non-classical, i.e. not signal peptide
triggered protein secretion we used the SecretomeP 1.0b
Server [22]http://www.cbs.dtu.dk/services/SecretomeP-
1.0/. The SecretomeP 1.0b server produces ab initio predic-
tions of non-classical protein secretion in eukaryotes. It
should be noted, however, that this approach is not nec-
essarily able to decide whether a given entry is an example
of leaderless secretion or it is a fragment of a classically
secreted protein (that lacks its signal peptide). To exclude
the latter possibility, we have also queried EST databases
to decide whether the initiating methionine is properly
defined or the open reading frame may be extended in the
upstream direction.
To further test whether a suspicious protein sequence
(sequence A) identified by one of the MisPred routines is
truly erroneous it was used as query to search protein and
nucleic acid sequence databases with blastp and tblastn,
respectively, to identify homologous sequences from the
same as well as from other species. If the search yielded a
perfect match (100% identity over at least 25 amino acid
residues) with a different protein sequence from the same
species (sequence B), but the latter protein was judged
'normal' by the same MisPred routine that identified
sequence A as suspicious then we concluded that the error
has been both validated and corrected (by sequence B). IfBMC Bioinformatics 2008, 9:353 http://www.biomedcentral.com/1471-2105/9/353
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the sequence similarity search identified close homologs
of sequence A (paralogs from the same species, orthologs
and/or paralogs from related species) but the latter pro-
tein(s) were judged 'normal' by the same MisPred routine
that identified sequence A as suspicious then we con-
cluded that the error has been validated. In the majority of
such cases the erroneous sequence A could be corrected
through targeted search of the appropriate genomic
region of the relevant species with various gene prediction
programs as well as search of EST databases, using the
'normal' homologous sequence(s) as queries. The proto-
col used for the correction of errors will be described in
another publication (manuscript in preparation).
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